ACTU: Actuate Therapeutics Inc. Kompaniya qiymatining sof foydaga nisbati

Actuate Therapeutics Inc. - ACTU emitenti grafik logotipi

GURU.Markets platformasida Actuate Therapeutics, Inc. (ACTU) aksiyalarining bozor tendentsiyasi, bunda ko'rsatkich -0.40 darajasida turibdi, murakkab o'smalar terapiyasining muvaffaqiyati va subyektlar guruhini shakllantirish sur'ati bilan belgilanadi. Joriy kotirovkalar tadqiqot va ishlanmalar (R&D) xarajatlarini hamda II bosqich sinovlari natijalariga bo'lgan kutishlarni hisobga olgan. Uzoq muddatda biznes onkologiya sektorida bozor ulushini egallash uchun elraglusib preparatining global targ'ibotiga asoslanadi.

Narx-foyda koeffitsiyenti: Actuate Therapeutics, Inc. (ACTU) 21.03.2025 - 17.11.2026 uchun

Actuate Therapeutics Inc. (ACTU) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning jamlanma tahlili:ACTU, Actuate Therapeutics
Actuate Therapeutics yetakchi tovari

P/E koeffitsiyenti biznesning bozor qiymatini uning yaratgan sof foydasiga nisbatan aks ettiradi. Kompaniyaning yillik P/E koeffitsiyentini tahlil qilish investorga aktivlarning haddan tashqari qimmat baholanishi va qarz xizmati risklarini tezda aniqlash imkonini beradi. Grafikdagi ushbu koeffitsiyentning tendentsiyasi kapital qiymati va o'sish sur'atlari o'rtasidagi muvozanatning ko'rsatkichi bo'lib xizmat qiladi. Actuate Therapeutics, Inc. (ACTU) uchun yuqori baholash ko'pincha uning ilmiy missiyasi va yetakchi onkologlarni saqlab qolish uchun foydalaniladigan opsion paketlarining qiymati bilan oqlanadi.

Muhim raqobatchilar

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|CTOR: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Fate Therapeutics Corp (FATE)|Narx-foyda koeffitsiyenti WHWK|Narx-foyda multiplikatori TCRX (TScan Therapeutics, Inc.)|P/E multiplikatori CSBR|XBIT - Kapitalizatsiyaning foydaga nisbati|CEL-SCI Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OSTX|radiopharmtheranostics.com - P/E multiplikatori|ARTV: Narxning foydaga nisbati|ANL (adlainortye.com) - Narx-foyda koeffitsiyenti|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV